Hospital stocks continue their three-day rally as the GOP health-care bill got postponed for the second time on Friday.
Health-care stock performance diverged Friday after the controversial GOP health care bill was pulled from the floor of the House.
NEW YORK— U.S. stocks gave back much of an early gain but were mostly higher Friday afternoon as investors bid up technology and consumer-focused companies. House Republicans say their health care bill does not have enough support to pass in a vote this afternoon, which is casting some doubt on President Donald Trump's business-friendly agenda.
The battle over Obamacare is causing a rift not only on Capitol Hill. The business community is divided, too.
Currently under Obamacare, insurers can deduct only up to $500,000 of executive compensation on their taxes.
Health insurers would be allowed to deduct their executives' salaries from their taxes, and not just the first $500,000.
U.S. Rep. Jason Chaffetz of Utah said lower-income Americans should stop buying expensive gadgets and focus on investing in their own health care.
EpiPen's seller Mylan came under fire last summer for having increased the price of the auto-injector more than 500 percent.
The president said 2017 will be a "catastrophic year for Obamacare for patients," citing rising premiums as a factor, NBC News reports.
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.
Last week, a federal judge blocked the deal, saying it would lead to higher prices and reduced competition.
CNBC's Bertha Coombs reports the latest on how Cigna is suing Anthem and expanding its buyback program to a total of $3.7 billion.
CNBC's Bertha Coombs reports the latest on Anthem responding by saying Cigna does not have the right to terminate the deal.
CNBC's Bertha Coombs reports the latest on Aetna and Humana ending their merger agreement after a court sided with the Justice Department objections to the combination.
Anthem will appeal a federal court ruling rejecting its $54 billion merger with Cigna and asked for an expedited hearing to make its case.
Is the end near for the Anthem-Cigna deal? CNBC's Bertha Coombs reports on where the deal currently stands.
A federal judge blocked Anthem's proposed $54-billion acquisition of its smaller rival Cigna.
Coca-Cola, Twitter, Anthem, and Cigna stocks are making headlines on Walll Street.
A federal judge ruled against U.S. health insurer Anthem's proposed $54 billion merger with smaller rival Cigna.
The ruling marks another victory for anti-trust officials, who sued the companies in July last year to stop the deal.